Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies by Jing Zeng, Jing Zeng, Rutie Yin, Rutie Yin

Get full text

AKT inhibitors in gynecologic oncology: past, present and future by Jinghong Chen, Rutie Yin

Get full text

Immune checkpoint inhibitor outcomes and prognostic factors in gynecologic tract melanoma: a single-center analysis by Jianzhang Wang, Kemin Li, Kemin Li, Rui Li, Rui Li, Jing Zeng, Jing Zeng, Rutie Yin, Rutie Yin

Get full text

Bibliometric analysis of research trends on the combination of radiotherapy and PARP inhibitors in solid tumors by Yuxin Chen, Zhengkun Zhang, Zhengkun Zhang, Rutie Yin, Rutie Yin, Qingli Li, Qingli Li, Wenhao Zhang, Wenhao Zhang

Get full text

Immunotherapy in gestational trophoblastic neoplasia: advances and future directions by Jing Zeng, Jing Zeng, Jing Zhang, Jing Zhang, Jianzhang Wang, Lian Xu, Lian Xu, Cheng Wang, Cheng Wang, Rutie Yin, Rutie Yin

Get full text

The clinical characteristics and prognostic analysis of 35 postterm choriocarcinomas by Lan Zhong, Rutie Yin, Qingli Li, Danqing Wang, Liang Song

Get full text

Bispecific antibodies: unleashing a new era in oncology treatment by Lin Shui, Dan Wu, Kaixuan Yang, Chuntang Sun, Qingli Li, Rutie Yin

Get full text

Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whol... by Jing Zeng, Jing Zeng, Qingli Li, Qingli Li, Kemin Li, Kemin Li, Lu Yang, Lu Yang, Lian Xu, Lian Xu, Wei Wang, Wei Wang, Kaixuan Yang, Kaixuan Yang, Qingbo Wei, Jin Wang, Changbin Zhu, Rutie Yin, Rutie Yin

Get full text